Neuren Pharmaceuticals Annual Report 2024

TWENTY LARGEST HOLDERS OF QUOTED ORDINARY SHARES Number of ordinary shares % of issued share capital 1 HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED 17,684,031 13.97 2 CITICORP NOMINEES PTY LIMITED 13,225,277 10.45 3 J P MORGAN NOMINEES AUSTRALIA PTY LIMITED 12,906,867 10.20 4 CAMERON RICHARD PTY LTD 4,355,222 3.44 5 BNP PARIBAS NOMS PTY LTD 4,056,178 3.20 6 STUART ANDREW PTY LTD 2,790,348 2.20 7 ESSEX CASTLE LIMITED 2,322,678 1.83 8 LINWIERIK SUPER PTY LTD 1,800,000 1.42 9 SMITHLEY SUPER PTY LTD 1,584,000 1.25 10 SHARESIES AUSTRALIA NOMINEE PTY LIMITED 1,497,609 1.18 11 NATIONAL NOMINEES LIMITED 1,143,545 0.90 12 FIRST COLBYCO PTY LTD 829,200 0.65 13 BNP PARIBAS NOMINEES PTY LTD 765,775 0.60 14 DR ROBIN LANCE CONGREVE 671,637 0.53 15 MJHFT PTY LTD 600,000 0.47 16 NETWEALTH INVESTMENTS LIMITED 560,073 0.44 17 CUSTODIAL SERVICES LIMITED 554,271 0.44 18 HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED - A/C 2 490,918 0.39 19 EMANCIPAYTE PTY LTD 463,141 0.37 20 BNP PARIBAS NOMINEES PTY LTD 434,135 0.34 Total 68,734,905 54.29 Balance of share register 57,861,116 45.71 Total ordinary shares quoted on ASX 126,596,021 100.00 SUBSTANTIAL SECURITY HOLDERS The following have filed substantial holding notifications based on the last notice lodged on the ASX: Number held Percentage The Vanguard Group, Inc. and its controlled entities1 6,492,295 5.023% 1 As disclosed in substantial holder notice dated 11 March 2025. ADDITIONAL INFORMATION CONTINUED Neuren Pharmaceuticals Limited Annual Report 2024 56

RkJQdWJsaXNoZXIy MjE2NDg3